JPRN-UMIN000008932招募中2 期
A phase II study of palonosetron to prevent nausea and vomiting induced by CHOP therapy in malignant lymphoma cancer patients. - A phase II study of palonosetron to prevent nausea and vomiting induced by CHOP therapy in malignant lymphoma cancer patients.
Hematology, Department of Medicine Kitasato University, School of Medicine0 个研究点目标入组 55 人开始时间: 2012年9月17日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) With other sever diseases 2) Clinical suspicion or history of metastasis to brain or meninges 3) Patients who need anticonvulsants therapy 4) Ascites and/or pleural effusion to need treatment 5) Pyloric stenosis and/or intestinal obstruction 6) Vomiting, or grade 2 or higher nausea according to CTCAE ver4.0 7) History of drug allergy 8) Pregnant or lactating women or women of childbearing potential, and no birth-control 9) Patient who doesn't have ability or intention that cooperates for procedure of the study 10) Not appropriate for the study at the physician's assessment
研究者
相似试验
已完成
2 期
A phase II study of palonosetron to prevent nausea and vomiting induced by chemotherapy in haematological malignancies.haematological malignanciesJPRN-UMIN000010746Hematology, Department of Medicine Kitasato University, School of Medicine50
进行中（未招募）
不适用
Phase II study with Palonosetron alone in preventing chemotherapy-induced nausea and vomiting in untreated patients with aggressive Non Hodgkin?s Lymphomas who underwent moderately emetogenic chemotherapy - Palonosetron in NHpreventing chemotherapy-induced nausea and vomiting in untreated patients with aggressive Non Hodgkin?s Lymphomas who underwent moderately emetogenic chemotherapy.MedDRA version: 9.1Level: HLTClassification code 10028817Term: Nausea and vomiting symptomsEUCTR2006-003189-33-ITG.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI
已完成
不适用
Efficacy of palonosetron plus aprepitant in preventing chemoradiotherapy-induced nausea and emesis in patients receiving daily low-dose cisplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a phase II studycervical cancerJPRN-UMIN000011616Chiba University Hospital20
已完成
不适用
The effect of Palonosetron for the prevention of postoperative nausea and vomitingKCT0000581Soon Chun Hyang University Hospital Seoul214
尚未招募
不适用
Efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomitting in patients with haematological malignancieshaematological malignanciesJPRN-UMIN000005733Tokushima University Hospital50